In addition, SFYXG could enhance the level of adenosine triphosphate (ATP) and improve cardiac in rats with HF by inhibiting the overexpression of uncoupling protein-2 (UCP-2) and weakening mitochondrion membrane potential. This evidence concerns the gene UCP2 and hydrops fetalis.